← Back to headlines
Raymond James Lowers Viking Therapeutics Price Target
Raymond James has lowered its price target for Viking Therapeutics, Inc. (VKTX), despite an optimistic outlook on the company's clinical initiatives.
4 Mar, 06:45 — 4 Mar, 06:45
Sources
Showing 1 of 1 sources
Related Stories
Revolut Secures Conditional U.S. National Bank Charter
24m ago
Ryanair Cuts Winter Flight Capacity and Warns of Fare Increases Amid High Fuel Costs
32m ago
Canada’s Trade Surplus Narrows in July Amid Falling Exports
38m ago
Snowflake Stock Soars After AI-Driven Revenue Growth Powers Blowout Quarter
49m ago